| Pharmaceutical active ingredients: |
| Diphenylpyraline Hydrochloride |
| Available forms, composition and doses of Lyssipoll: |
| N / A |
| Lyssipoll medical category: |
| Human:Anticholinergic drugsAntihistamines first-generation |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R06AA07 - Diphenylpyraline |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Solvay |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Arbid N | Diphenylpyraline Hydrochloride | Gepepharm |
| Hispril | Diphenylpyraline Hydrochloride | GlaxoSmithKline |
| Histalert | Diphenylpyraline Hydrochloride | 3M |
| Histryl | Diphenylpyraline Hydrochloride | GlaxoSmithKline |
| Lergoban | Diphenylpyraline Hydrochloride | 3M |
| Rhinamide | Diphenylpyraline Hydrochloride; Ephedrine Hydrochloride; Sulfanilamide | Vitalpharma |
| Doregrippin S | Diphenylpyraline Hydrochloride; Ethenzamide | Dr. Rentschler Arzneimittel |
| Eskold Expectorant | Diphenylpyraline Hydrochloride; Guaifenesin; Phenylpropanolamine Hydrochloride | GlaxoSmithKline |
| Solucodan-H | Diphenylpyraline Hydrochloride; Hydrocodone Bitartrate; Menthol; Potassium Guaiacolsulfonate; Sodium Citrate | Rougier Pharma |
| Biohisdex DHC Decongestant | Diphenylpyraline Hydrochloride; Hydrocodone Tartrate; Phenylephrine Hydrochloride | Everest Pharmaceuticals |